Healthcare Sales & Marketing Network News: Osiris Therapeutics

Searching News Database: Osiris Therapeutics

HSMN NewsFeed - 24 Nov 2020
Elevian Announces $15 Million Equity Financing
Biopharmaceuticals Regenerative Medicine Venture Capital

HSMN NewsFeed - 2 Apr 2019
Provention Bio Announces Key Additions to its Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 12 Mar 2019
Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc.
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 31 Mar 2017
Osiris Therapeutics Launches Prestige(TM) Lyotechnology, a Novel Method for Ambient Storage of Living Cells and Tissues
Regenerative Medicine Product Launch

HSMN NewsFeed - 20 Jan 2017
Osiris Therapeutics announced a Comparative Effectiveness Study on the Use of Two Human Placental Membranes in Wound Management is Available Electronically in a Peer-Reviewed Journal
Devices Wound Care

HSMN NewsFeed - 7 Oct 2016
Osiris Therapeutics Announces Appointment of Alberto Avendano, M.D. as Chief Medical Officer
Regenerative Medicine Personnel

HSMN NewsFeed - 17 May 2016
MiMedx Files Lawsuit Against Osiris For False And Misleading Representations
Regenerative Medicine Wound Care Litigation

HSMN NewsFeed - 29 Oct 2015
Bellicum Appoints Alan K. Smith as Senior Vice President of Manufacturing
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 24 Apr 2014
Grafix(R) Pharmacoeconomic and Scientific Characterization Studies Featured at the 2014 Spring Symposium for Advanced Wound Care
Devices Regenerative Medicine Wound Care

HSMN NewsFeed - 26 Mar 2014
Osiris Therapeutics Announces Ther�sa K. Dixon as General Manager of Market Access and Reimbursement
Regenerative Medicine Personnel

HSMN NewsFeed - 12 Feb 2014
Osiris Therapeutics Promotes Frank Czworka to Vice President and General Manager of Wound Care
Devices Regenerative Medicine Wound Care Personnel

HSMN NewsFeed - 14 Jan 2014
Osiris Therapeutics Board Confirms Lode Debrabandere, PhD, MBA, as President and Chief Executive Officer
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 29 Nov 2013
Osiris Provides Update on Proposed Ruling by CMS
Devices Regenerative Medicine Wound Care Reimbursement

HSMN NewsFeed - 1 Mar 2013
Osiris Therapeutics Establishes Direct Sales Force for Grafix(R)
Devices Regenerative Medicine Wound Care Distribution

HSMN NewsFeed - 5 Nov 2012
Amedica Names Distinguished Health Care Industry Executive Jay M. Moyes To Board Of Directors
Devices Orthopaedic Neurosurgery Personnel

HSMN NewsFeed - 22 Oct 2012
Osiris Therapeutics Names Lode Debrabandere Chief Operating Officer
Regenerative Medicine Wound Care Personnel

HSMN NewsFeed - 28 Sep 2012
Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen
Regenerative Medicine

HSMN NewsFeed - 8 Feb 2011
Osiris Therapeutics Strengthens Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Jan 2011
BioCardia elects Industry Veteran, Jay M. Moyes, to Board of Directors
Devices Regenerative Medicine Cardiology Personnel

HSMN NewsFeed - 15 Dec 2010
Orthofix International Announces Reorganization And Settlement with NuVasive and Osiris Therapeutics
Devices Orthopaedic Neurosurgery Litigation

HSMN NewsFeed - 24 Feb 2010
New Study Demonstrates Effectiveness of Prochymal as a Rescue Therapy for Pediatric Patients with Severe Graft vs. Host Disease
Biopharmaceuticals

HSMN NewsFeed - 8 Sep 2009
Osiris Therapeutics Announces Preliminary Results for Prochymal Phase III GvHD Trials
Biopharmaceuticals

HSMN NewsFeed - 9 Jun 2009
AssureRx Adds New CEO
Biopharmaceuticals Diagnostics Personnel

HSMN NewsFeed - 12 Feb 2009
Osiris Reports Positive Two-Year Data on Stem Cell Treatment for Acute Myocardial Infarction
Regenerative Medicine Cardiology

HSMN NewsFeed - 15 Jan 2009
Osiris Receives FDA Clearance to Broaden Prochymal Expanded Access Program
Regenerative Medicine FDA

HSMN NewsFeed - 15 Jan 2009
Osiris and FDA Reach Agreement on Submission of First Marketing Application for a Stem Cell Product
Regenerative Medicine FDA

HSMN NewsFeed - 5 Dec 2008
Osiris Receives Approval for Prochymal Expanded Access Program in Canada
Biopharmaceuticals Regenerative Medicine Regulatory

HSMN NewsFeed - 28 Jul 2008
Osiris Therapeutics Appoints Chief Financial Officer
Biopharmaceuticals Regenerative Medicine Personnel

HSMN NewsFeed - 8 May 2008
NuVasive Signs Definitive Agreement to Acquire Osteocel Biologics Business from Osiris Therapeutics
Regenerative Medicine Acquisitions

HSMN NewsFeed - 8 May 2008
Osiris and NuVasive Enter into Definitive Agreement for Osteocel(R)
Regenerative Medicine

HSMN NewsFeed - 8 May 2008
Osiris Receives Approval for Use of Prochymal(TM) Under FDA Expanded Access Treatment Program
Regenerative Medicine FDA

HSMN NewsFeed - 27 Feb 2008
Osiris Therapeutics Strengthens Management Team
Regenerative Medicine Personnel

HSMN NewsFeed - 7 Jan 2008
Osiris Therapeutics Regains Worldwide Rights to Cardiovascular Indications for Prochymal(TM)
Regenerative Medicine Cardiology

HSMN NewsFeed - 10 Dec 2007
Osiris Therapeutics Reports Positive Results for Prochymal(TM) as a Rescue Agent in Pediatric Patients with End-Stage Graft vs. Host Disease
Regenerative Medicine

HSMN NewsFeed - 27 Nov 2007
Osiris Therapeutics Announces Positive One Year Data from Chondrogen Trial for Knee Repair
Regenerative Medicine Orthopaedic

HSMN NewsFeed - 23 Nov 2007
Osiris Therapeutics Announces Management Change
Regenerative Medicine Personnel

HSMN NewsFeed - 9 Oct 2007
Osiris Therapeutics Secures $30 Million Financing Commitment from Chairman and Largest Shareholder
Regenerative Medicine

HSMN NewsFeed - 7 Aug 2007
BD Taps Seasoned Executive and Researcher to Serve as Company's Chief Technology Officer
Devices Personnel

HSMN NewsFeed - 8 Jan 2007
Osiris Therapeutics Receives FDA Fast Track Status for Its Crohn's Disease Stem Cell Therapy and Clearance to Start Phase III Clinical Trial
Regenerative Medicine Gastroenterology

HSMN NewsFeed - 9 Dec 2006
Osiris Therapeutics Provides Update on Phase II Trial Evaluating PROCHYMAL(TM) for the Treatment of Acute Graft vs. Host Disease
Biopharmaceuticals

HSMN NewsFeed - 9 Nov 2006
Osiris Therapeutics Reports Positive Phase II Results Using PROCHYMAL(TM) for the Treatment of Acute Graft vs. Host Disease
Biopharmaceuticals Regenerative Medicine

HSMN NewsFeed - 19 Oct 2006
Osiris Therapeutics Reports Positive Phase II Results Using PROCHYMAL(TM) in Treatment-Resistant Crohn's Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 17 Oct 2006
Osiris is Granted European Manufacturing Certification for PROCHYMAL(TM)
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Oct 2006
Osiris Therapeutics Receives Approval from Health Canada to Conduct Phase III Clinical Trial for Lead Stem Cell Drug
Biopharmaceuticals Regenerative Medicine Regulatory

HSMN NewsFeed - 22 Sep 2006
Blackstone Medical, Inc. Advances Spine Treatment with New Product Launches at NASS '06
Devices Orthopaedic Neurosurgery

HSMN NewsFeed - 14 Aug 2006
Osiris Announces Expansion of Board of Directors and Key Additions to its Senior Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 10 Aug 2006
Blackstone Medical, Inc. Is Acquired by Orthofix International N.V. for US$ 333 Million
Devices Orthopaedic Neurosurgery Mergers & Acquisitions

HSMN NewsFeed - 25 Apr 2006
Osiris Completes Enrollment in Stem Cell Trial for Knee Repair
Regenerative Medicine Orthopaedic

HSMN NewsFeed - 5 Apr 2006
Osiris Completes Enrollment in Stem Cell Trial to Treat Cardiac Disease
Biopharmaceuticals Regenerative Medicine Cardiology

HSMN NewsFeed - 10 Mar 2006
Blackstone Medical Plays Major Role in Spine Medicine Technology at First Stem Cell Summit in Chicago
Regenerative Medicine Orthopaedic Neurosurgery

Return to NewsFeed

Additional items found! 20

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 20 additional stories matching:
Osiris Therapeutics
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.